Prostate Hyperplasia in a Transgenic Mouse with Prostate-Specific Expression of Prolactin [PDF]
, 2003 Jon Kindblom +6 more
openalex +1 more source
The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia [PDF]
, 2021 Wei Zhang +8 more
openalex +1 more source
Radiogenomics: Current Understandings and Future Perspectives
MedComm, Volume 7, Issue 2, February 2026.Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang +8 more
wiley +1 more source
Population Pharmacokinetics of a Novel Oral Fosfomycin Prophylactic Scheme in the Plasma and Prostate of Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia [PDF]
Pier Giorgio Cojutti +7 more
openalex +1 more source
Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population [PDF]
, 2014 Ho-Sik Seok +5 more
openalex +1 more source
Peripheral Nerves in Cancer: Regulatory Roles and Therapeutic Strategies
MedComm, Volume 7, Issue 2, February 2026.The interaction between cancer cells and peripheral nerves: (1) tumor cells could induce the growth of new neural axons and constructing a neural fiber network within the tumor tissue through secreting nerve growth factors; (2) nerve‐derived bioactive molecules can induce perineural invasion of tumor and regulate the malignant phenotype of tumor, such ...
Yan Fu +6 more
wiley +1 more source
Beyond Baseline: Serial PSA Measurements and Risk Stratification for Prostate Cancer
The Prostate, Volume 86, Issue 4, Page 505-507, March 2026.
Anwar E. Ahmed, Bassam Dahman
wiley +1 more source
The Prostate, Volume 86, Issue 3, Page 307-313, February 15, 2026.ABSTRACT Background Prostate cancer (PCa) is the most common solid organ cancer in men and the fifth leading cause of cancer‐related deaths globally. PSA helps identify men at risk but has low specificity and has resulted in unnecessary biopsies. The PROSTest, a novel machine learning‐based 27‐gene mRNA liquid biopsy assay, was developed to detect PCa.
Mark Kidd +5 more
wiley +1 more source